Raksha-Ovac monovalent (O strain)
Product Description
Indian Immunologicals Ltd
-
IN
-
2019On CPHI since
-
1000 - 4999Employees
Company types
Categories
Indian Immunologicals Ltd
-
IN
-
2019On CPHI since
-
1000 - 4999Employees
Company types
More Products from Indian Immunologicals Ltd (56)
-
Product Raksha SP + PPR freeze dried
sheep pox + PPR vaccine (Peste des Petits ruminants vaccine) composition: Each 1mL contains: sheep pox virus titer ≥ 10TCID50 [propagated on Vero cells] PPr virus titer ≥ 102.5 TCID50 [propagated on Vero cells], sucrose and lactalbumin hydrolysate addes as stabilizers. sterile diluent: Each 1mL contains... -
Product Raksha Trivalent
Each dose contains: FMD inactivated antigens of O, A and Asia-1 strains adsorbed on to aluminium hydroxide gel. Saponin added as adjuvant chlorofom B.P as preservative 0.015mL, phosphate buffer diluent q.s -
Product Raksha- HS (M& H)
HS vaccine (multocida & haemolytica) Each dose contains pasteurella multocida I.P (vet.) and M. haemolytica B.P (Vet.) (formerly known as pasteurella haemolytica), inactivated antigens adsorbed on aluminium hydroxide gel, formaldehyde as preservative -
Product Raksha-ET Enterotoxaemia vaccine
Raksha-ET vaccine contains inactivated culture of anaerobically grown Clostridium Welchii Type – D organisms. The prototoxin is converted into toxin by trypsinization. The toxin is then rendered non-toxic by formalisation. This is then adjuvanted with aluminium hydroxide gel. -
Product Raksha-Monovalent
Each dose contains: Monovalent FMD inactivated antigen of O strain adsorbed on to aluminium hydroxide gel. Saponin added as adjuvant chlorofom B.P as preservative 0.015mL, phosphate buffer diluent q.s -
Product Raksha-Ovac monovalent (Asia-1 strain)
Each dose contains: monovalent FMD inactivated antigens of Asia-1 strain adsorbed on to aluminium hydroxide gel. Mineral oil added as adjuvant thiomersal B.P as preservative ≤ 0.02% w/v, phosphate buffer diluent q.s -
Product Raksha-PPR Peste des petits ruminants vaccine
Peste des Petits ruminants vaccine, live Each dose contains: PPR virus titer ≥ 102.5 TCID 50 [propagated on vero cells], maltose, gelatin and lactalbumin hydrolysate added as stabilizer Sterile diluent: Each 1mL contains: disodium hydrogen ortho phosphate anhydrous B.P, potassium dihydrogen phosphate B.P,... -
Product Rakshavac - T Theileriosis vaccine
Rakshavac-T (Theileriosis vaccine, Live I.P.) is indicated for preventive vaccination against tropical Theileriosis (Theileria annulata) infection in cattle. Theileria annulata strain -
Product Sheep pox vaccine, live attenuated, I.P
composition: Each dose contains: sheep pox virus titre ≥103 TCID 50 [propagated on vero cells], sucrose and lactalbumin hydrolysate added as stabilizers. Sterile diluent composition: Each 1mL contains: disodium hydrogen ortho phosphate, anhydrous B.P, potassium dihydrogen orhtophosphate B.P, sodium chlori... -
Product Vaxtar-5
Diphtheria, Tetanus, Pertussis (Whole Cell), Hepatitis B (rDNA) and Haemophilus influenzae Type b Conjugate Vaccine (Adsorbed) I.P -
Product Xylazine inj. 20 mg/ml (2%)
Xylaxin injection is recommended for inducing sedation and analgesia in various animals, for restraining of animals for routine observations, minor surgical interventions, immobilization of animals during transportation and transhipment or any similar functions. -
Product Havisure
The Inactivated Hepatitis A vaccine (Adsorbed) I.P. is a sterile, ready to use suspension containing inactivated Hepatitis A virus (strain HM175), propagated in MRC-5 human diploid cells and adsorbed on aluminum hydroxide. The vaccine appears as off-white suspension which settles down on standing into two ...
Indian Immunologicals Ltd resources (2)
-
News COVID-19 VACCINE DEVELOPMENT
Indian Immunologicals Limited, in collaboaration with Griffith University, Australia is going to commence research for developing a vaccine for Corona virus, the pandemic which has infected more than two million and killed about 250,00 people across the world.
Even WHO has considered the same in its latest draft landscape of COVID 19 vaccine candidates dated 30th April, 2020.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance